Governing ethical clinical research in developing countries: exploring the case of Mexico

Fernando Santiago

Science and Public Policy, 2010, vol. 37, issue 8, 583-596

Abstract: Observance of acceptable ethical behaviour is compulsory for good research, particularly when such research puts the well-being of humans at risk. Internationalization of clinical research in developing countries raises ethical concerns. Are the study subjects aware of, and sufficiently protected against, the inherent risks of drug testing? Public policy is called upon to minimize risks while increasing the opportunities for host countries to benefit from participation in clinical research. This paper discusses some minimum principles required for clinical trials to be ethical. Based on evidence from Mexico, the paper illustrates how factors such as: slow regulatory reforms, insufficient empowerment of regulatory agencies, and disconnection among agents increase the risks of unethical behaviour in clinical research. Copyright , Beech Tree Publishing.

Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.3152/030234210X12767691861010 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:scippl:v:37:y:2010:i:8:p:583-596

Access Statistics for this article

Science and Public Policy is currently edited by Nicoletta Corrocher, Jeong-Dong Lee, Mireille Matt and Nicholas Vonortas

More articles in Science and Public Policy from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().